-
1
المؤلفون: Timmer, TCG, Kasperkovitz, PV, van Baarsen, LGM, Tak, P-P, Huizinga, TWJ, Kraan, TCTM van der Pouw, Verweij, CL
المصدر: Arthritis Research & Therapy
مصطلحات موضوعية: Poster Presentation
-
2
المؤلفون: Kasperkovitz, PV, Timmer, T, Smeets, T, Tak, PP, Huizinga, TWJ, Firestein, GS, Rustenburg, F, van der Pouw Kraan, TCTM, Fero, M, Verweij, CL
المصدر: Arthritis Research & Therapy
مصطلحات موضوعية: Oral Presentation
-
3
المؤلفون: Kasperkovitz, PV, Verbeet, NL, Smeets, T, Tak, PP, Huizinga, TWJ, Baltus, B, Timmer, T, Pieterman, E, Fero, M, Firestein, GS, Alizadeh, AA, van der Pouw Kraan, TCTM, Verweij, CL
المصدر: Arthritis Research & Therapy
مصطلحات موضوعية: Meeting Abstract
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Khan NS; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Biomedical Engineering and Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Biomedical Engineering and Biotechnology, University of Massachusetts Lowell, Lowell, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Lukason DP; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Feliu M; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Ward RA; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Lord AK; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Reedy JL; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ramirez-Ortiz ZG; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Tam JM; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Kasperkovitz PV; F. Hoffmann-La Roche Innovation Center Basel, Basel, Switzerland., Negoro PE; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Vyas TD; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Xu S; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Brinkmann MM; Viral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.; Institute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany., Acharaya M; Benaroya Research Institute, Seattle, Washington, USA.; Center for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, Washington, USA., Artavanis-Tsakonas K; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Frickel EM; Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, United Kingdom., Becker CE; Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Dagher Z; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Kim YM; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Latz E; Department of Medicine, University of Massachusetts Medical School, Boston, Massachusetts, USA.; Institute of Innate Immunity, University Hospital Bonn, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Ploegh HL; Boston Children's Hospital, Boston, Massachusetts, USA., Mansour MK; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Miranti CK; Laboratory of Integrin Signaling and Tumorigenesis, Van Andel Research Institute, Grand Rapids, Michigan, USA.; Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA., Levitz SM; Department of Medicine, University of Massachusetts Medical School, Boston, Massachusetts, USA., Vyas JM; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
المصدر: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2019 Nov; Vol. 33 (11), pp. 12500-12514. Date of Electronic Publication: 2019 Aug 13.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
مواضيع طبية MeSH: Cell Nucleus/*immunology , Kangai-1 Protein/*immunology , Macrophages/*immunology , Oligodeoxyribonucleotides/*pharmacology , Signal Transduction/*drug effects , Toll-Like Receptor 9/*immunology, Active Transport, Cell Nucleus/drug effects ; Active Transport, Cell Nucleus/genetics ; Active Transport, Cell Nucleus/immunology ; Animals ; Cell Nucleus/genetics ; Cytokines/genetics ; Cytokines/immunology ; Endoplasmic Reticulum/genetics ; Endoplasmic Reticulum/immunology ; Endoplasmic Reticulum/pathology ; Inflammation/genetics ; Inflammation/immunology ; Inflammation/pathology ; Kangai-1 Protein/genetics ; Macrophages/pathology ; Mice ; Mice, Knockout ; NF-kappa B/genetics ; NF-kappa B/immunology ; RAW 264.7 Cells ; Signal Transduction/genetics ; Signal Transduction/immunology ; Toll-Like Receptor 9/genetics
-
10دورية أكاديمية
المؤلفون: Janas MM; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts., Jiang Y; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts., Duncan RG; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts., Hayes AN; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts., Liu J; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts., Kasperkovitz PV; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts., Placke ME; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts., Barros SA; Alnylam Pharmaceuticals, Inc. , Cambridge, Massachusetts.
المصدر: Nucleic acid therapeutics [Nucleic Acid Ther] 2016 Dec; Vol. 26 (6), pp. 363-371. Date of Electronic Publication: 2016 Jul 07.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-3345 (Electronic) Linking ISSN: 21593337 NLM ISO Abbreviation: Nucleic Acid Ther Subsets: MEDLINE
مواضيع طبية MeSH: Acetylgalactosamine/*chemistry , Bone Marrow/*drug effects , Glycoconjugates/*chemistry , Lymphocytes/*drug effects , RNA, Small Interfering/*chemistry, Acetylgalactosamine/metabolism ; Acetylgalactosamine/pharmacology ; Animals ; Biotransformation ; Bone Marrow/physiology ; CHO Cells ; Cricetulus ; DNA Breaks, Double-Stranded/drug effects ; Endocytosis ; Glycoconjugates/metabolism ; Glycoconjugates/pharmacology ; HeLa Cells ; Hep G2 Cells ; Humans ; Lymphocytes/physiology ; Micronucleus Tests ; Mutagenicity Tests ; Primary Cell Culture ; RNA Cleavage ; RNA, Small Interfering/metabolism ; RNA, Small Interfering/pharmacology ; Rats